Home > Riviste > European Journal of Physical and Rehabilitation Medicine > Fascicoli precedenti > European Journal of Physical and Rehabilitation Medicine 2017 October;53(5) > European Journal of Physical and Rehabilitation Medicine 2017 October;53(5):798-801

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE

Rivista di Medicina Fisica e Riabilitativa dopo Eventi Patologici


Official Journal of the Italian Society of Physical and Rehabilitation Medicine (SIMFER), European Society of Physical and Rehabilitation Medicine (ESPRM), European Union of Medical Specialists - Physical and Rehabilitation Medicine Section (UEMS-PRM), Mediterranean Forum of Physical and Rehabilitation Medicine (MFPRM), Hellenic Society of Physical and Rehabilitation Medicine (EEFIAP)
In association with International Society of Physical and Rehabilitation Medicine (ISPRM)
Indexed/Abstracted in: CINAHL, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,827


eTOC

 

CASE REPORT  FREEfree


European Journal of Physical and Rehabilitation Medicine 2017 October;53(5):798-801

DOI: 10.23736/S1973-9087.17.04499-9

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Efficacy of botulinum toxin type-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with lateral medullary syndrome

Irene BATTEL 1 , Isabella KOCH 1, Federica BIDDAU 1, Carla CAROLLO 1, Francesco PICCIONE 1, Francesca MENEGHELLO 1, Antonio MERICO 1, Katie PALMER 1, Rosario MARCHESE RAGONA 2

1 Neuroriabilitation Hospital Foundation IRCCS San Camillo, Venice, Italy; 2 Department of Neurosciences and Sense Organs, AO Padua, Padua, Italy


PDF  


BACKGROUND: Wallenberg’s syndrome (WS) is known as posterior inferior cerebellar artery syndrome. Dysphagia has been reported from 51% to 94% of the patients, ranging from mild to severe.
CASE REPORT: We reported a case of a patient (male; 52 years) with WS. MRI showed an intense hypodense area in the dorsolateral part of the ponto-medullary junction. The clinical signs were severe dysphagia, fed by PEG (FOIS 1; PAS 7), sialorrhea, trismus and ataxia.
CLINICAL REHABILITATION IMPACT: Dysphagia was treated by botulinum toxin type-A (BoNT-A), which was injected into the parotid and submandibular salivary glands, temporalis and masseter muscles, cricopharyngeal muscle associated with specific swallowing exercise and food trails. The 3-months follow-up showed significant saliva reduction and improvement of swallowing to from PEG feeding to consistent oral intake of food (FOIS 3, PAS 5). The treatment with BoNT-A combined with swallowing rehabilitation was fundamental in order to restore the swallowing functions.


KEY WORDS: Lateral medullary syndrome - Botulinum toxins, type A - Deglutition disorders - Sialorrhea

inizio pagina

Publication History

Issue published online: October 31, 2017
Article first published online: March 6, 2017
Manuscript accepted: February 28, 2017
Manuscript revised: February 8, 2017
Manuscript received: September 21, 2016

Per citare questo articolo

Battel I, Koch I, Biddau F, Carollo C, Piccione F, Meneghello F, et al. Efficacy of botulinum toxin type-A and swallowing treatment for oropharyngeal dysphagia recovery in a patient with lateral medullary syndrome. Eur J Phys Rehabil Med 2017;53:798-801. DOI: 10.23736/S1973-9087.17.04499-9

Corresponding author e-mail

irene.battel@ospedalesancamillo.net